A study of 99 elderly women from Baltimore, which was published online Wednesday in the journal Neurology, found that those who had a middle or high level of the fat known as serum ceramides were eight- to tenfold more likely to develop Alzheimer’s within nine years…It’s not the first substance in the body to possibly indicate the presence or progression of Alzheimer’s disease. But whereas most of the other biomarkers require getting a brain scan or a lumbar puncture to collect spinal fluid, serum ceramides can be obtained from a blood sample, said lead author Michelle M. Mielke, an epidemiologist with the Mayo Clinic in Rochester, Minn.
Additional coverage: HealthDay, CBC.ca, CBS KDKA Pa., CBS WROC NY
Chicago Sun-Times by Monifa Thomas
Tags: alzheimer's disease, biomarkers, Chicago Sun-Times, Dr. Michelle Mielke, elderly women, Mayo Clinic Rochester, Neurology, Research, serum ceramides